Senseonics Holdings (SENS) Preferred Stock Liabilities (2020 - 2024)
Senseonics Holdings' (SENS) quarterly Preferred Stock Liabilities came in at $37.7 million in Q4 2024, little changed year-on-year from $37.7 million in Q1 2024, and little changed on a QoQ basis from $37.7 million in Q3 2024.
Senseonics Holdings (SENS) Preferred Stock Liabilities (2020 - 2024) Analysis & Trends
Senseonics Holdings (SENS) has 4 years of Preferred Stock Liabilities data on file, last reported at $37.7 million in Q4 2024.
- On a quarterly basis, Preferred Stock Liabilities changed 0.0% year-over-year to $37.7 million in Q4 2024; TTM through Dec 2024 was $37.7 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $37.7 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities for Q4 2024 stood at $37.7 million, roughly flat from $37.7 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for SENS reached as high as $37.7 million in Q4 2022 and fell as low as $2.8 million in Q3 2020.
- Historically, Preferred Stock Liabilities has averaged $31.3 million across 4 years, with a median of $37.7 million in 2022.
- On a YoY basis, Preferred Stock Liabilities climbed as much as 0.0% in 2023 and fell as far as 0.0% in 2023.
- Year by year, Preferred Stock Liabilities stood at $2.8 million in 2020, then surged by 1239.59% to $37.7 million in 2022, then changed by 0.0% to $37.7 million in 2023, then changed by 0.0% to $37.7 million in 2024.
- Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $37.7 million in Q4 2024, $37.7 million in Q3 2024, and $37.7 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | - |
| 10 | Senseonics Holdings | 232.78 Mn | 168.46 Mn | 6.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 37.66 Mn |
| Sep 30, 2024 | 37.66 Mn |
| Jun 30, 2024 | 37.66 Mn |
| Mar 31, 2024 | 37.66 Mn |
| Dec 31, 2023 | 37.66 Mn |
| Sep 30, 2023 | 37.66 Mn |
| Jun 30, 2023 | 37.66 Mn |
| Mar 31, 2023 | 37.66 Mn |
| Dec 31, 2022 | 37.66 Mn |
| Dec 31, 2020 | 2.81 Mn |
| Sep 30, 2020 | 2.81 Mn |